COVID-19

The Return to Only Seeing the Oncology Patient for Their Consult

Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Oncology patients once again need to see the doctor alone amid the return of COVID-related restrictions, and navigators should help ensure the patient comprehends the medical information as intended.

Uncertainty as the Pandemic Continues

Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
As the COVID-19 pandemic continues on longer than we anticipated, oncology navigators need to check in with their patients to evaluate their mental health in this time of uncertainty.

The COVID-19 Pandemic’s Impact on Cancer Incidence

Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
The COVID-19 pandemic has presented more questions than it has answers, especially when determining how it will affect cancer incidence in the future.

Coping with the Delta Variant

Victoria Atkinson, MD,Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
The coronavirus’s delta variant has presented new challenges for patients with cancer.

Long-term Consequences of Delayed Cancer Screenings

Andrea (Andi) Dwyer, BS
As we begin to move forward from the COVID-19 pandemic, there are long-term consequences of the delay in cancer screenings that need to be addressed immediately.

Assisting Patients in Timely Cancer Screenings

Andrea (Andi) Dwyer, BS
Oncology navigators can help their patients feel comfortable to come in for cancer screenings by educating them and empowering them with the knowledge they need to make informed decisions.

How are Hospitals Keeping Patients Safe During the Pandemic?

Andrea (Andi) Dwyer, BS
Hospitals and medical providers are following safety and cleaning guidelines and considering capacity to minimize risk of COVID-19 for patients.

Hesitancy Around Cancer Screenings During COVID-19

Andrea (Andi) Dwyer, BS
Andi Dwyer, BS, shares how hesitancy around cancer screenings during COVID-19 could lead to a rise in cancer cases.

Cancer Rates in 2021

Andrea (Andi) Dwyer, BS
Patients who delayed their cancer screenings due to the pandemic are now joining patients who were scheduled for screenings in 2021, leading to a large patient volume for institutions to consider.

COVID-19 Impact on Cancer Screenings

Andrea (Andi) Dwyer, BS
Andi Dwyer, BS, explains how the COVID-19 pandemic delayed many cancer screenings for the average-risk population.